Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-19-036699
Filing Date
2019-07-30
Accepted
2019-07-30 17:25:49
Documents
1
Group Members
ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLCATLAS VENTURE ASSOCIATES X, L.P.ATLAS VENTURE ASSOCIATES X, LLCATLAS VENTURE OPPORTUNITY FUND I, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tv526124_sc13d.htm SC 13D 161544
  Complete submission text file 0001144204-19-036699.txt   163459
Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Fund X, L.P. (Filed by) CIK: 0001628098 (see all company filings)

EIN.: 472435989 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Subject) CIK: 0001681087 (see all company filings)

EIN.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90532 | Film No.: 19986512
SIC: 2836 Biological Products, (No Diagnostic Substances)